JFrog (FROG) CFO planned share sales total 21,702
Rhea-AI Filing Summary
JFrog Ltd Chief Financial Officer Eduard Grabscheid reported open-market sales of a total of 21,702 ordinary shares of the company. The sales took place on March 2 and 3, 2026 at weighted average prices of about $40.15 and $40.32 per share, respectively. According to the disclosure, these transactions were executed under a pre-arranged Rule 10b5-1 trading plan, and the footnotes note that some shares were sold to cover tax withholding on vested restricted stock units. After these sales, Grabscheid directly holds 233,839 ordinary shares of JFrog.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 6,063 | $40.32 | $244K |
| Sale | Ordinary Shares | 15,639 | $40.15 | $628K |
Footnotes (1)
- Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) and does not represent a discretionary sale by the Reporting Person. Includes 366 ordinary shares purchased pursuant to the JFrog Ltd. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period ended February 28, 2026. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's ordinary shares on February 27, 2026. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2025. This transaction was executed in multiple trades at prices ranging from $40.06 to $40.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
FAQ
What insider transaction did JFrog (FROG) report for its CFO?
Does the JFrog (FROG) Form 4 indicate planned or discretionary sales by the CFO?